» Articles » PMID: 1898993

Signal Transduction by Interferon-alpha Through Arachidonic Acid Metabolism

Overview
Journal Science
Specialty Science
Date 1991 Jan 11
PMID 1898993
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular mechanisms that mediate signal transduction by growth inhibitory cytokines are poorly understood. Type I (alpha and beta) interferons (IFNs) are potent growth inhibitory cytokines whose biological activities depend on induced changes in gene expression. IFN-alpha induced the transient activation of phospholipase A2 in 3T3 fibroblasts and rapid hydrolysis of [3H]arachidonic acid (AA) from prelabeled phospholipid pools. The phospholipase inhibitor, bromophenacyl bromide (BPB), specifically blocked IFN-induced binding of nuclear factors to a conserved, IFN-regulated enhancer element, the interferon-stimulated response element (ISRE). BPB also caused a dose-dependent inhibition of IFN-alpha-induced ISRE-dependent transcription in transient transfection assays. Specific inhibition of AA oxygenation by eicosatetraynoic acid prevented IFN-alpha induction of factor binding to the ISRE. Treatment of intact cells with inhibitors of fatty acid cyclooxygenase or lipoxygenase enzymes resulted in amplification of IFN-alpha-induced ISRE binding and gene expression. Thus, IFN-alpha receptor-coupled AA hydrolysis may function in activation of latent transcription factors by IFN-alpha and provides a system for studying the role of AA metabolism in transduction of growth inhibitory signals.

Citing Articles

Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.

Das U Arch Med Sci. 2023; 19(5):1327-1359.

PMID: 37732033 PMC: 10507771. DOI: 10.5114/aoms/135703.


Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.

Su K, Huang S, Peng C, Lai H, Huang C, Chen Y Biol Psychiatry. 2009; 67(6):550-7.

PMID: 20034614 PMC: 2982743. DOI: 10.1016/j.biopsych.2009.11.005.


Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.

Gramenzi A, Cursaro C, Margotti M, Balsano C, Spaziani A, Anticoli S World J Gastroenterol. 2009; 15(47):5946-52.

PMID: 20014458 PMC: 2795181. DOI: 10.3748/wjg.15.5946.


Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Jeong S, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H World J Gastroenterol. 2007; 13(40):5343-50.

PMID: 17879404 PMC: 4171324. DOI: 10.3748/wjg.v13.i40.5343.


Fatty acid transport across lipid bilayer planar membranes.

Curi R, Peres C, Brunaldi K, Abdulkader F, Procopio J Lipids. 2000; 35(1):31-4.

PMID: 10695921 DOI: 10.1007/s11745-000-0491-4.